Category: Articles
-
Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma
The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma. Read More
-
Absci to Collaborate with the Memorial Sloan Kettering Cancer Center to Develop Biologics using AI
The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI. Read More
-
MSD to Acquire Bispecific Antibody From Curon in Bid to Diversify Portfolio
The novel investigational clinical stage bispecific antibody targets CD3xCD19 to engage T cells with malignant B cells. Read More
-
RSC ‘Emerging Technologies’ Award Goes to Solid Phase Peptide Synthesis Group
The novel peptide synthesis protocol allows the synthesis of multiple peptide fragments on a single bead. Read More
-
CAR T Beyond Cancer: Applying the Cell Therapy for Lupus and Other Autoimmune Diseases
Can CAR T, which has had successes in immuno-oncology, be applied to reset the immune system of autoimmune disease patients? Read More
-
Blood Biomarkers Signal Increased Risk of Alzheimer’s & MND After Multiple Rugby Concussions
Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development. Read More
-
FDA Fast Track ADC for Patients with Triple Negative Breast Cancer
The fast track designation means that the clinical development and regulatory milestones of the drug candidate are likely to progress much faster. Read More
-
Scientists Develop First Mouse Model with Complete & Functional Human Immune System
The breakthrough in mouse models will allow researchers to study the human immune system in far greater detail at a far greater pace. Read More
-
Life Science Players Join €23m European Project for Precision Medicine, PRECISEU
The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products. Read More
-
GSK Buys CureVac’s mRNA Vaccine Business Providing Welcome Cash Injection
CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines. Read More